Morningstar® Stock Report™

The Cooper Companies Inc COO

Último Precio
91.68
Cambio del día
1.64|1.82%

a 23/04/2024
17:55:54 EDT | USD  Retraso mínimo: 15 minutos

Bid/OffersRango del DíaVolumen90d Ave VolCapitalización
90.01 - 93.3289.98 - 92.04874,9621,123,64618.22Bil
Último Cierre52 Week RangeP/UDividendo %ISIN
90.0475.94 - 104.0762.900.01US2166485019

Cotización The Cooper Companies Inc

Mr. Lee Davidson, Head of Quantitative Research
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
Cuentas Financieras
202120222023
Más...
Cuenta de Resultados
Ingresos2,922.503,308.403,593.20
Resultado Operativo505.80507.60533.10
Resultado Neto2,944.70385.80294.20
Beneficio Básico por Acción14.951.961.49
Num Medio Acciones diluidas en circulación199199199
Balance
Activo Corriente1,465.301,533.601,704.90
Activos no corrientes8,140.909,958.709,954.00
Total Activo 9,606.2011,492.3011,658.90
Pasivo corriente732.101,280.20969.00
Total Pasivo---
Capital Total6,941.807,174.507,550.80
Flujo de Caja
Flujo de caja operativo738.60692.40607.50
Inversiones de Capital-214.40-242.00-392.50
Flujo de Caja Libre524.20450.40215.00

En millones, excepto "EPS básico". La moneda es USD.

Perfil de la compañía

The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women’s care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

Sector

Atención sanitaria

Industria

Instrumentos y Suministros Médicos

Estilo de acciones

Media-Mixto

Fin Ejercicio Fiscal

octubre

Empleados

15,000
Principales Características
Más...
Precio/Beneficio 12 m61.46
Precio/Valor contable2.33
Precio/Ventas TTM4.90
Crec Ingresos (media 3 a)13.91
Crec BPA (media 3 a)-
Margen operativo14.84
Margen neto8.19
ROE 12 m4.00
Deuda/Fondos propios0.33
Dividendos
AntÚltimo
Fecha declarada14/12/2212/07/23
Ex-Div20/01/2326/07/23
Pagado10/02/2311/08/23
Cantidad0.010.01
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures